1. Home
  2. ELUT vs IROQ Comparison

ELUT vs IROQ Comparison

Compare ELUT & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • IROQ
  • Stock Information
  • Founded
  • ELUT 2015
  • IROQ 1883
  • Country
  • ELUT United States
  • IROQ United States
  • Employees
  • ELUT N/A
  • IROQ N/A
  • Industry
  • ELUT Medical Specialities
  • IROQ Savings Institutions
  • Sector
  • ELUT Health Care
  • IROQ Finance
  • Exchange
  • ELUT Nasdaq
  • IROQ Nasdaq
  • Market Cap
  • ELUT 88.4M
  • IROQ 79.4M
  • IPO Year
  • ELUT 2020
  • IROQ 2011
  • Fundamental
  • Price
  • ELUT $2.09
  • IROQ $25.15
  • Analyst Decision
  • ELUT Strong Buy
  • IROQ
  • Analyst Count
  • ELUT 2
  • IROQ 0
  • Target Price
  • ELUT $8.00
  • IROQ N/A
  • AVG Volume (30 Days)
  • ELUT 29.0K
  • IROQ 964.0
  • Earning Date
  • ELUT 08-14-2025
  • IROQ 09-02-2025
  • Dividend Yield
  • ELUT N/A
  • IROQ 1.59%
  • EPS Growth
  • ELUT N/A
  • IROQ 69.23
  • EPS
  • ELUT N/A
  • IROQ 1.05
  • Revenue
  • ELUT $23,683,000.00
  • IROQ $25,099,000.00
  • Revenue This Year
  • ELUT $20.10
  • IROQ N/A
  • Revenue Next Year
  • ELUT $85.89
  • IROQ N/A
  • P/E Ratio
  • ELUT N/A
  • IROQ $24.02
  • Revenue Growth
  • ELUT N/A
  • IROQ 12.02
  • 52 Week Low
  • ELUT $1.61
  • IROQ $17.42
  • 52 Week High
  • ELUT $5.12
  • IROQ $25.76
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 52.40
  • IROQ 62.40
  • Support Level
  • ELUT $1.96
  • IROQ $24.90
  • Resistance Level
  • ELUT $2.30
  • IROQ $25.29
  • Average True Range (ATR)
  • ELUT 0.14
  • IROQ 0.06
  • MACD
  • ELUT 0.01
  • IROQ 0.01
  • Stochastic Oscillator
  • ELUT 45.03
  • IROQ 62.22

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About IROQ IF Bancorp Inc.

IF Bancorp Inc is a holding company. It is mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company with the association take deposits from the general public and invest those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, others and also a variety of deposit accounts and alternative delivery channels.

Share on Social Networks: